We may only be one month into 2026, but the Centers for Medicare & Medicaid Services (CMS) is already planning the prices for ...

PBMs typically receive a portion of rebates paid by drug manufacturers, the majority of which are passed back to the payer as an incentive to prefer a drug on a formulary. PBMs may also retain revenue ...

The Senate passed a spending package Friday, but the measure is still awaiting House approval. House Speaker Mike Johnson ...

Let’s discuss how to apply online, along with a few problems we are discovering in helping others apply for Medicare at ...

Paying into the Medicare system doesn't guarantee free health insurance in retirement; it comes with deductibles and premiums like standard health insurance. Unfortunately, both are going up this year ...

For the first time, CMS has released negotiated prices for high-cost drugs covered under both Medicare Part D and Part B, ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

CMS's proposed 0.09% Medicare Advantage rate hike for 2027 triggered a sharp sell-off across US health insurers, signaling ...

Negotiations Will Occur in 2026 With Negotiated Prices Effective in 2028.8, 2026 - On Tuesday, the Centers for Medicare & ...

The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...